Healthy Clinical Trial
— MEEGAPERFOfficial title:
Electrophysiological and Bioenergetic Study of Variations in Cognitive and Physical Performance in Healthy Humans: EEG Monitoring for PERFormance Anticipation
NCT number | NCT03233282 |
Other study ID # | 69HCL16_0661 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 30, 2013 |
Est. completion date | May 31, 2018 |
Verified date | August 2018 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Identify, characterize and then validate electrophysiological markers linking electrophysiological cerebral activity and performance in cognitive and physical fatigability in humans. To do this, noninvasive explorations of electroencephalography (EEG) and magnetoencephalography (MEG) will be carried out under two conditions of different experiments, the first one that induces a cognitive fatigability and the second one that induces physical fatigability.
Status | Completed |
Enrollment | 169 |
Est. completion date | May 31, 2018 |
Est. primary completion date | May 31, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria MGPFco group: - Adult subjects, male or female, right-handed or left-handed, from 18 years up to 70 years; - Having duly completed the entire confidential medical questionnaire; - Written consent of free, informed and express participation; - No hearing problems; - Having normal or corrected vision; - Affiliation to a Social Security scheme. Inclusion Criteria MGPFph group: - Adult subjects, male or female, right-handed or left-handed, from 18 years up to 35 years; - Practicing at least five hours of sports per week; - Presenting a certificate of no contraindication to an exercise test, intense sports practice or an energy sport in competition of the current year; - Having duly completed the entire confidential medical questionnaire; - Without cardiovascular or motor disability; - Without tumoral, inflammatory, cardiac, pulmonary, renal, digestive (malabsorption syndrome) or liver disease; - Written consent of free, informed and express participation; - Affiliation to a Social Security scheme. Exclusion Criteria: - Pregnant women, nursing mothers or those of childbearing age without contraception - Persons under guardianship, curatorship or any other administrative or judicial measure of deprivation of liberty or of liberty - Persons protected by the law - Persons who have performed a maximum stress test within 15 days of the date of inclusion, - In the course of drug treatments against indicated for the protocol (treatment for neurological diseases, psychiatric ...). - Metal implants incompatible with MRI (for the subjects concerned, see appendices) - Metallic implants incompatible with the MEG (for the subjects concerned, see appendices) |
Country | Name | City | State |
---|---|---|---|
France | Hospices Civils de Lyon, HFME | Bron |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Identify electrophysiological markers in humans depending on whether the experimental conditions induce cognitive fatigability. | The evaluation of cognitive performance will be carried out by means of conventional behavioral measures, of the press-button type, handling of a mouse or of a joystick and measurement of reaction time. | 7 hours | |
Primary | Identify electrophysiological markers in humans depending on whether the experimental conditions induce physical fatigability with EEG. | Electrophysiological measurements of cerebral activity will be performed by multi-sensor electroencephalography (EEG). | 7 hours | |
Primary | Identify electrophysiological markers in humans depending on whether the experimental conditions induce physical fatigability with MEG. | Electrophysiological measurements of cerebral activity will be carried out by magnetoencephalography (MEG) | 7 hours | |
Secondary | Refine (locate at the level of the cortex), the origin of these physiological markers | Several types of recordings, passive and non-invasive, will be realized: Electrooculogram (EOG); electromyography (EMG); electrocardiogram (ECG); Systematically in "physical" experiments and for some "cognitive" experiments. |
7 hours | |
Secondary | Distinguish between different time scales of performance | Several types of recordings, passive and non-invasive, will be realized: electrodermogram (EDG); the consumption of O2 (VO2); production of CO2 (VCO2). Only and systematically, in "physical" experiments. |
7 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |